0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV Clinical Trials Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-20Q11657
Home | Market Reports | Health| Reproductive Health
Global HIV Clinical Trials Market Research Report 2022

Global HIV Clinical Trials Market Research Report 2022

Code: QYRE-Auto-20Q11657
Report
August 2022
93 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
HIV clinical trials help researchers find better ways to prevent, detect, or treat HIV. Examples of HIVclinical trials underway include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV.
Highlights

The global HIV Clinical Trials market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for HIV Clinical Trials is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for HIV Clinical Trials is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The global market for HIV Clinical Trials in Pharmaceutical & Biopharmaceutical Companies is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global companies of HIV Clinical Trials include PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc. and Bionor Holding AS, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

Considering the economic change due to COVID-19, Phase I, which accounted for % of the global market of HIV Clinical Trials in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for HIV Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Clinical Trials.
The HIV Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global HIV Clinical Trials market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
PPD Inc.
IQVIA Inc.
Parexel International Corporation
ICON plc
Syneos Health
WuXi AppTec
Janssen Global Services, LLC
Gilead Sciences, Inc.
Bionor Holding AS
Charles River Laboratories
GSK plc.
SGS SA
Product Type Insights
Global markets are presented by HIV Clinical Trials type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the HIV Clinical Trials are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

HIV Clinical Trials segment by Type

Phase I
Phase II
Phase III
Phase IV
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the HIV Clinical Trials market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the HIV Clinical Trials market.

HIV Clinical Trials Segment by Application

Pharmaceutical & Biopharmaceutical Companies
Non Profit Organizations
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the HIV Clinical Trials market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of HIV Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the HIV Clinical Trials industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Clinical Trials.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Clinical Trials Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global HIV Clinical Trials Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Non Profit Organizations
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global HIV Clinical Trials Market Perspective (2017-2028)
2.2 HIV Clinical Trials Growth Trends by Region
2.2.1 HIV Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 HIV Clinical Trials Historic Market Size by Region (2017-2022)
2.2.3 HIV Clinical Trials Forecasted Market Size by Region (2023-2028)
2.3 HIV Clinical Trials Market Dynamics
2.3.1 HIV Clinical Trials Industry Trends
2.3.2 HIV Clinical Trials Market Drivers
2.3.3 HIV Clinical Trials Market Challenges
2.3.4 HIV Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Clinical Trials Players by Revenue
3.1.1 Global Top HIV Clinical Trials Players by Revenue (2017-2022)
3.1.2 Global HIV Clinical Trials Revenue Market Share by Players (2017-2022)
3.2 Global HIV Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV Clinical Trials Revenue
3.4 Global HIV Clinical Trials Market Concentration Ratio
3.4.1 Global HIV Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Clinical Trials Revenue in 2021
3.5 HIV Clinical Trials Key Players Head office and Area Served
3.6 Key Players HIV Clinical Trials Product Solution and Service
3.7 Date of Enter into HIV Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Clinical Trials Breakdown Data by Type
4.1 Global HIV Clinical Trials Historic Market Size by Type (2017-2022)
4.2 Global HIV Clinical Trials Forecasted Market Size by Type (2023-2028)
5 HIV Clinical Trials Breakdown Data by Application
5.1 Global HIV Clinical Trials Historic Market Size by Application (2017-2022)
5.2 Global HIV Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America HIV Clinical Trials Market Size (2017-2028)
6.2 North America HIV Clinical Trials Market Size by Country (2017-2022)
6.3 North America HIV Clinical Trials Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe HIV Clinical Trials Market Size (2017-2028)
7.2 Europe HIV Clinical Trials Market Size by Country (2017-2022)
7.3 Europe HIV Clinical Trials Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Clinical Trials Market Size (2017-2028)
8.2 Asia-Pacific HIV Clinical Trials Market Size by Country (2017-2022)
8.3 Asia-Pacific HIV Clinical Trials Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America HIV Clinical Trials Market Size (2017-2028)
9.2 Latin America HIV Clinical Trials Market Size by Country (2017-2022)
9.3 Latin America HIV Clinical Trials Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Clinical Trials Market Size (2017-2028)
10.2 Middle East & Africa HIV Clinical Trials Market Size by Country (2017-2022)
10.3 Middle East & Africa HIV Clinical Trials Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 PPD Inc.
11.1.1 PPD Inc. Company Detail
11.1.2 PPD Inc. Business Overview
11.1.3 PPD Inc. HIV Clinical Trials Introduction
11.1.4 PPD Inc. Revenue in HIV Clinical Trials Business (2017-2022)
11.1.5 PPD Inc. Recent Development
11.2 IQVIA Inc.
11.2.1 IQVIA Inc. Company Detail
11.2.2 IQVIA Inc. Business Overview
11.2.3 IQVIA Inc. HIV Clinical Trials Introduction
11.2.4 IQVIA Inc. Revenue in HIV Clinical Trials Business (2017-2022)
11.2.5 IQVIA Inc. Recent Development
11.3 Parexel International Corporation
11.3.1 Parexel International Corporation Company Detail
11.3.2 Parexel International Corporation Business Overview
11.3.3 Parexel International Corporation HIV Clinical Trials Introduction
11.3.4 Parexel International Corporation Revenue in HIV Clinical Trials Business (2017-2022)
11.3.5 Parexel International Corporation Recent Development
11.4 ICON plc
11.4.1 ICON plc Company Detail
11.4.2 ICON plc Business Overview
11.4.3 ICON plc HIV Clinical Trials Introduction
11.4.4 ICON plc Revenue in HIV Clinical Trials Business (2017-2022)
11.4.5 ICON plc Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Detail
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health HIV Clinical Trials Introduction
11.5.4 Syneos Health Revenue in HIV Clinical Trials Business (2017-2022)
11.5.5 Syneos Health Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Detail
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec HIV Clinical Trials Introduction
11.6.4 WuXi AppTec Revenue in HIV Clinical Trials Business (2017-2022)
11.6.5 WuXi AppTec Recent Development
11.7 Janssen Global Services, LLC
11.7.1 Janssen Global Services, LLC Company Detail
11.7.2 Janssen Global Services, LLC Business Overview
11.7.3 Janssen Global Services, LLC HIV Clinical Trials Introduction
11.7.4 Janssen Global Services, LLC Revenue in HIV Clinical Trials Business (2017-2022)
11.7.5 Janssen Global Services, LLC Recent Development
11.8 Gilead Sciences, Inc.
11.8.1 Gilead Sciences, Inc. Company Detail
11.8.2 Gilead Sciences, Inc. Business Overview
11.8.3 Gilead Sciences, Inc. HIV Clinical Trials Introduction
11.8.4 Gilead Sciences, Inc. Revenue in HIV Clinical Trials Business (2017-2022)
11.8.5 Gilead Sciences, Inc. Recent Development
11.9 Bionor Holding AS
11.9.1 Bionor Holding AS Company Detail
11.9.2 Bionor Holding AS Business Overview
11.9.3 Bionor Holding AS HIV Clinical Trials Introduction
11.9.4 Bionor Holding AS Revenue in HIV Clinical Trials Business (2017-2022)
11.9.5 Bionor Holding AS Recent Development
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Detail
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories HIV Clinical Trials Introduction
11.10.4 Charles River Laboratories Revenue in HIV Clinical Trials Business (2017-2022)
11.10.5 Charles River Laboratories Recent Development
11.11 GSK plc.
11.11.1 GSK plc. Company Detail
11.11.2 GSK plc. Business Overview
11.11.3 GSK plc. HIV Clinical Trials Introduction
11.11.4 GSK plc. Revenue in HIV Clinical Trials Business (2017-2022)
11.11.5 GSK plc. Recent Development
11.12 SGS SA
11.12.1 SGS SA Company Detail
11.12.2 SGS SA Business Overview
11.12.3 SGS SA HIV Clinical Trials Introduction
11.12.4 SGS SA Revenue in HIV Clinical Trials Business (2017-2022)
11.12.5 SGS SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global HIV Clinical Trials Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Phase I
    Table 3. Key Players of Phase II
    Table 4. Key Players of Phase III
    Table 5. Key Players of Phase IV
    Table 6. Global HIV Clinical Trials Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global HIV Clinical Trials Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global HIV Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global HIV Clinical Trials Market Share by Region (2017-2022)
    Table 10. Global HIV Clinical Trials Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global HIV Clinical Trials Market Share by Region (2023-2028)
    Table 12. HIV Clinical Trials Market Trends
    Table 13. HIV Clinical Trials Market Drivers
    Table 14. HIV Clinical Trials Market Challenges
    Table 15. HIV Clinical Trials Market Restraints
    Table 16. Global HIV Clinical Trials Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global HIV Clinical Trials Market Share by Players (2017-2022)
    Table 18. Global Top HIV Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Clinical Trials as of 2021)
    Table 19. Ranking of Global Top HIV Clinical Trials Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by HIV Clinical Trials Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players HIV Clinical Trials Product Solution and Service
    Table 23. Date of Enter into HIV Clinical Trials Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global HIV Clinical Trials Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global HIV Clinical Trials Revenue Market Share by Type (2017-2022)
    Table 27. Global HIV Clinical Trials Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global HIV Clinical Trials Revenue Market Share by Type (2023-2028)
    Table 29. Global HIV Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global HIV Clinical Trials Revenue Market Share by Application (2017-2022)
    Table 31. Global HIV Clinical Trials Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global HIV Clinical Trials Revenue Market Share by Application (2023-2028)
    Table 33. North America HIV Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America HIV Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe HIV Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe HIV Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific HIV Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific HIV Clinical Trials Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America HIV Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America HIV Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa HIV Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa HIV Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
    Table 43. PPD Inc. Company Detail
    Table 44. PPD Inc. Business Overview
    Table 45. PPD Inc. HIV Clinical Trials Product
    Table 46. PPD Inc. Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 47. PPD Inc. Recent Development
    Table 48. IQVIA Inc. Company Detail
    Table 49. IQVIA Inc. Business Overview
    Table 50. IQVIA Inc. HIV Clinical Trials Product
    Table 51. IQVIA Inc. Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 52. IQVIA Inc. Recent Development
    Table 53. Parexel International Corporation Company Detail
    Table 54. Parexel International Corporation Business Overview
    Table 55. Parexel International Corporation HIV Clinical Trials Product
    Table 56. Parexel International Corporation Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 57. Parexel International Corporation Recent Development
    Table 58. ICON plc Company Detail
    Table 59. ICON plc Business Overview
    Table 60. ICON plc HIV Clinical Trials Product
    Table 61. ICON plc Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 62. ICON plc Recent Development
    Table 63. Syneos Health Company Detail
    Table 64. Syneos Health Business Overview
    Table 65. Syneos Health HIV Clinical Trials Product
    Table 66. Syneos Health Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 67. Syneos Health Recent Development
    Table 68. WuXi AppTec Company Detail
    Table 69. WuXi AppTec Business Overview
    Table 70. WuXi AppTec HIV Clinical Trials Product
    Table 71. WuXi AppTec Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 72. WuXi AppTec Recent Development
    Table 73. Janssen Global Services, LLC Company Detail
    Table 74. Janssen Global Services, LLC Business Overview
    Table 75. Janssen Global Services, LLC HIV Clinical Trials Product
    Table 76. Janssen Global Services, LLC Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 77. Janssen Global Services, LLC Recent Development
    Table 78. Gilead Sciences, Inc. Company Detail
    Table 79. Gilead Sciences, Inc. Business Overview
    Table 80. Gilead Sciences, Inc. HIV Clinical Trials Product
    Table 81. Gilead Sciences, Inc. Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 82. Gilead Sciences, Inc. Recent Development
    Table 83. Bionor Holding AS Company Detail
    Table 84. Bionor Holding AS Business Overview
    Table 85. Bionor Holding AS HIV Clinical Trials Product
    Table 86. Bionor Holding AS Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 87. Bionor Holding AS Recent Development
    Table 88. Charles River Laboratories Company Detail
    Table 89. Charles River Laboratories Business Overview
    Table 90. Charles River Laboratories HIV Clinical Trials Product
    Table 91. Charles River Laboratories Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 92. Charles River Laboratories Recent Development
    Table 93. GSK plc. Company Detail
    Table 94. GSK plc. Business Overview
    Table 95. GSK plc. HIV Clinical TrialsProduct
    Table 96. GSK plc. Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 97. GSK plc. Recent Development
    Table 98. SGS SA Company Detail
    Table 99. SGS SA Business Overview
    Table 100. SGS SA HIV Clinical TrialsProduct
    Table 101. SGS SA Revenue in HIV Clinical Trials Business (2017-2022) & (US$ Million)
    Table 102. SGS SA Recent Development
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global HIV Clinical Trials Market Share by Type: 2021 VS 2028
    Figure 2. Phase I Features
    Figure 3. Phase II Features
    Figure 4. Phase III Features
    Figure 5. Phase IV Features
    Figure 6. Global HIV Clinical Trials Market Share by Application in 2021 & 2028
    Figure 7. Pharmaceutical & Biopharmaceutical Companies Case Studies
    Figure 8. Non Profit Organizations Case Studies
    Figure 9. Others Case Studies
    Figure 10. HIV Clinical Trials Report Years Considered
    Figure 11. Global HIV Clinical Trials Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global HIV Clinical Trials Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global HIV Clinical Trials Market Share by Region: 2021 VS 2028
    Figure 14. Global HIV Clinical Trials Market Share by Players in 2021
    Figure 15. Global Top HIV Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Clinical Trials as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by HIV Clinical Trials Revenue in 2021
    Figure 17. North America HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America HIV Clinical Trials Market Share by Country (2017-2028)
    Figure 19. United States HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe HIV Clinical Trials Market Share by Country (2017-2028)
    Figure 23. Germany HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific HIV Clinical Trials Market Share by Region (2017-2028)
    Figure 31. China HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America HIV Clinical Trials Market Share by Country (2017-2028)
    Figure 39. Mexico HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa HIV Clinical Trials Market Share by Country (2017-2028)
    Figure 43. Turkey HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia HIV Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. PPD Inc. Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 46. IQVIA Inc. Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 47. Parexel International Corporation Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 48. ICON plc Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 49. Syneos Health Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 50. WuXi AppTec Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 51. Janssen Global Services, LLC Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 52. Gilead Sciences, Inc. Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 53. Bionor Holding AS Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 54. Charles River Laboratories Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 55. GSK plc. Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 56. SGS SA Revenue Growth Rate in HIV Clinical Trials Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS